Zangi L - Search Results

1

Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.

Chien KR, Zangi L, Lui KO. Chien KR, et al. Among authors: zangi l. Cold Spring Harb Perspect Med. 2014 Oct 9;5(1):a014035. doi: 10.1101/cshperspect.a014035. Cold Spring Harb Perspect Med. 2014. PMID: 25301935 Free PMC article. Review.

2

A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells.

Später D, Abramczuk MK, Buac K, Zangi L, Stachel MW, Clarke J, Sahara M, Ludwig A, Chien KR. Später D, et al. Among authors: zangi l. Nat Cell Biol. 2013 Sep;15(9):1098-106. doi: 10.1038/ncb2824. Epub 2013 Aug 25. Nat Cell Biol. 2013. PMID: 23974038

3

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction.

Zangi L, Lui KO, von Gise A, Ma Q, Ebina W, Ptaszek LM, Später D, Xu H, Tabebordbar M, Gorbatov R, Sena B, Nahrendorf M, Briscoe DM, Li RA, Wagers AJ, Rossi DJ, Pu WT, Chien KR. Zangi L, et al. Nat Biotechnol. 2013 Oct;31(10):898-907. doi: 10.1038/nbt.2682. Epub 2013 Sep 8. Nat Biotechnol. 2013. PMID: 24013197 Free PMC article.

4

Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA.

Lui KO, Zangi L, Silva EA, Bu L, Sahara M, Li RA, Mooney DJ, Chien KR. Lui KO, et al. Among authors: zangi l. Cell Res. 2013 Oct;23(10):1172-86. doi: 10.1038/cr.2013.112. Epub 2013 Sep 10. Cell Res. 2013. PMID: 24018375 Free PMC article.

5

Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.

Wang G, McCain ML, Yang L, He A, Pasqualini FS, Agarwal A, Yuan H, Jiang D, Zhang D, Zangi L, Geva J, Roberts AE, Ma Q, Ding J, Chen J, Wang DZ, Li K, Wang J, Wanders RJ, Kulik W, Vaz FM, Laflamme MA, Murry CE, Chien KR, Kelley RI, Church GM, Parker KK, Pu WT. Wang G, et al. Among authors: zangi l. Nat Med. 2014 Jun;20(6):616-23. doi: 10.1038/nm.3545. Epub 2014 May 11. Nat Med. 2014. PMID: 24813252 Free PMC article.

6

Cardiovascular regenerative therapeutics via synthetic paracrine factor modified mRNA.

Lui KO, Zangi L, Chien KR. Lui KO, et al. Among authors: zangi l. Stem Cell Res. 2014 Nov;13(3 Pt B):693-704. doi: 10.1016/j.scr.2014.06.007. Epub 2014 Jul 8. Stem Cell Res. 2014. PMID: 25043723 Free article. Review.

7

How to make a cardiomyocyte.

Später D, Hansson EM, Zangi L, Chien KR. Später D, et al. Among authors: zangi l. Development. 2014 Dec;141(23):4418-31. doi: 10.1242/dev.091538. Epub 2014 Nov 18. Development. 2014. PMID: 25406392 Review.

8

Insulin-Like Growth Factor 1 Receptor-Dependent Pathway Drives Epicardial Adipose Tissue Formation After Myocardial Injury.

Zangi L, Oliveira MS, Ye LY, Ma Q, Sultana N, Hadas Y, Chepurko E, Später D, Zhou B, Chew WL, Ebina W, Abrial M, Wang QD, Pu WT, Chien KR. Zangi L, et al. Circulation. 2017 Jan 3;135(1):59-72. doi: 10.1161/CIRCULATIONAHA.116.022064. Epub 2016 Nov 1. Circulation. 2017. PMID: 27803039 Free PMC article.

9

Synthesis of Modified mRNA for Myocardial Delivery.

Kondrat J, Sultana N, Zangi L. Kondrat J, et al. Among authors: zangi l. Methods Mol Biol. 2017;1521:127-138. doi: 10.1007/978-1-4939-6588-5_8. Methods Mol Biol. 2017. PMID: 27910045

10

Optimizing Cardiac Delivery of Modified mRNA.

Sultana N, Magadum A, Hadas Y, Kondrat J, Singh N, Youssef E, Calderon D, Chepurko E, Dubois N, Hajjar RJ, Zangi L. Sultana N, et al. Among authors: zangi l. Mol Ther. 2017 Jun 7;25(6):1306-1315. doi: 10.1016/j.ymthe.2017.03.016. Epub 2017 Apr 4. Mol Ther. 2017. PMID: 28389322 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters